EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effect of an electronic antiemetic device (EAD) stimulating the Neiguan acupoint (PC6) on chemotherapy-induced nausea and vomiting in cancer patients: A randomised controlled trial

Dong Fan, Xiaoyu Wang, Xiaohua Liu, Yanqiu Song, Guijie Guo, Chunling Du, Weifeng Li

European Journal of Oncology Nursing · 2026-04 · 81 · 103172

DOI: 10.1016/j.ejon.2026.103172 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Oncology Nursing, 2026-04. Verfasst von Dong Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China. Electronic address: 184448084@qq.com. Hauptthemen laut MEDLINE: Vomiting, Nausea, Acupuncture Points, Antiemetics. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Shandong Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To assess the effectiveness of an electronic antiemetic device (EAD) stimulating the Neiguan acupoint (PC6) in preventing and alleviating chemotherapy-induced nausea and vomiting (CINV) in cancer patients, with a particular focus on delayed-phase CINV. The safety of the device was also assessed. METHODS 126 cancer patients who were scheduled to undergo chemotherapy that was either moderately or highly emetogenic were enrolled in this single-centre, randomised controlled experiment. Block randomisation was used to allocate participants in a 1:1 ratio to either the control group (ondansetron alone) or the experimental group (EAD plus ondansetron). The experimental group received EAD stimulation at the PC6 prior to chemotherapy and continued its use throughout the entire chemotherapy cycle, in addition to ondansetron, whereas the control group received only ondansetron. The complete response rate (CRR) and no emesis rate of acute and delayed CINV, symptom severity, quality of life (QoL), and the incidence of adverse events were assessed. RESULTS In the intention-to-treat population (n = 126), no significant differences were observed for acute nausea (CRR: ARR = 9.5%, 95% CI -1.0 to 20.0, P = 0.076; no emesis rate: ARR = 11.1%, 95% CI -0.5 to 22.7, P = 0.061). However, the experimental group had significantly higher delayed nausea CRR (ARR = 44.4%, 95% CI 29.8 to 59.1, P < 0.001) and delayed vomiting no emesis rate (ARR = 12.7%, 95% CI 1.2 to 24.2, P = 0.031). FLIE scores were higher in the experimental group during both acute (MD = 10.0, 95% CI -3.5 to 23.5, P = 0.146) and delayed phases (MD = 30.1, 95% CI 18.5 to 41.5, P < 0.001). The incidence of several gastrointestinal and systemic adverse events (CTCAE Grade≥2) was also lower in the experimental group (all P < 0.05). CONCLUSION Stimulation of the PC6 with an EAD significantly alleviates delayed CINV and lowers the incidence of adverse events, although its efficacy on acute CINV is less pronounced. These findings require validation in blinded, multicentre trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VomitingNauseaAcupuncture PointsAntiemeticsAntineoplastic AgentsElectroacupunctureNeoplasmsHumansFemaleMaleMiddle AgedOndansetronAdultTreatment OutcomeAgedQuality of Life

Stichwörter der Autor:innen

Chemotherapy-induced nausea and vomitingElectronic antiemetic deviceNeiguan acupoint (PC6)Nonpharmacological therapyQuality of life

Substanzen

AntiemeticsAntineoplastic AgentsOndansetron

Autor:innen und Institutionen

  • Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China. Electronic address: 184448084@qq.com.
  • School of Nursing, Shandong First Medical University, Tai'an, Shandong Province, China. Electronic address: wangxiaoyu965@163.com.
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China. Electronic address: 1971028113@qq.com.
  • School of Nursing, Shandong First Medical University, Tai'an, Shandong Province, China. Electronic address: syq1071485154@163.com.
  • School of Nursing, Shandong First Medical University, Tai'an, Shandong Province, China. Electronic address: 15964486272@163.com.
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China. Electronic address: 147855010@qq.com.

Förderung

  • Shandong Provincial Health Commission

Zitieren

APA

Fan, D., Wang, X., Liu, X., Song, Y., Guo, G., Du, C., & Li, W. (2026). Effect of an electronic antiemetic device (EAD) stimulating the Neiguan acupoint (PC6) on chemotherapy-induced nausea and vomiting in cancer patients: A randomised controlled trial. European Journal of Oncology Nursing, 81, 103172. https://doi.org/10.1016/j.ejon.2026.103172

Vancouver

Fan D, Wang X, Liu X, Song Y, Guo G, Du C, et al. Effect of an electronic antiemetic device (EAD) stimulating the Neiguan acupoint (PC6) on chemotherapy-induced nausea and vomiting in cancer patients: A randomised controlled trial. European Journal of Oncology Nursing. 2026;81:103172. doi:10.1016/j.ejon.2026.103172

BibTeX
@article{Fan2026,
  author = {Fan, Dong and Wang, Xiaoyu and Liu, Xiaohua and Song, Yanqiu and Guo, Guijie and Du, Chunling and Li, Weifeng},
  title = {Effect of an electronic antiemetic device (EAD) stimulating the Neiguan acupoint (PC6) on chemotherapy-induced nausea and vomiting in cancer patients: A randomised controlled trial},
  journal = {European Journal of Oncology Nursing},
  year = {2026},
  volume = {81},
  pages = {103172},
  doi = {10.1016/j.ejon.2026.103172}
}
Kostenlos starten →